Contact
Please use this form to send email to PR contact of this press release:
Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201
TO:
Please use this form to send email to PR contact of this press release:
Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201
TO: